A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K
- 16 July 2003
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (17), 3709-3727
- https://doi.org/10.1021/jm0301078
Abstract
A novel series of nonpeptidic biaryl compounds was identified as potent and reversible inhibitors of cathepsin K. The P2-P3 amide bond of a known amino acetonitrile dipeptide 1 was replaced with a phenyl ring, thereby giving rise to this biaryl series that retained potency vs cathepsin K and showed an improved selectivity profile against other cathepsins. Structural modification within this series resulted in the identification of compound (R)-2, a potent human cathepsin K inhibitor (IC(50) = 3 nM) that is selective versus cathepsins B (IC(50) = 3950 nM), L (IC(50) = 3725 nM), and S (IC(50) = 2010 nM). In an in vitro assay involving rabbit osteoclasts and bovine bone, compound (R)-2 inhibited bone resorption with an IC(50) of 95 nM. It was shown that, unlike some peptidic nitrile inhibitors of cysteine proteases, the nitrile moiety of (R)-2 is not converted to the corresponding amide 3 by cathepsin K. This indicates that this class of nonpeptidic nitrile inhibitors is unlikely to be hydrolyzed by cysteine proteases. Furthermore, the inhibition of cathepsin K by compound (R)-2 was shown to be fully reversible and not observably time-dependent. To demonstrate the efficacy of compound (R)-2 in vivo, it was administered to ovariectomized (OVX) rhesus monkeys at 20 mg/kg, po once daily for 8 days, and a urinary marker of bone turnover, N-telopeptide of type I collagen (uNTx), was measured. During the eight-day dosing period, the mean reduction by compound (R)-2 in uNTx was 80% (p < 0.001). This demonstrates that inhibition of cathepsin K leads to an inhibition of this bone resorption marker in OVX rhesus monkeys and strongly suggests that inhibition of cathepsin K is a viable therapeutic approach for the treatment of osteoporosis.Keywords
This publication has 16 references indexed in Scilit:
- Human and Parasitic Papain-Like Cysteine Proteases: Their Role in Physiology and Pathology and Recent Developments in Inhibitor DesignChemical Reviews, 2002
- Recent advances in the synthesis, design and selection of cysteine protease inhibitorsCurrent Opinion in Chemical Biology, 2002
- Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug DesignJournal of Medicinal Chemistry, 2001
- Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and LJournal of Medicinal Chemistry, 2000
- Lysosomal cysteine proteases: more than scavengersBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T‐lymphocytesFEBS Letters, 1997
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsJournal of Biological Chemistry, 1996
- Proteolytic Activity of Human Osteoclast Cathepsin KJournal of Biological Chemistry, 1996
- Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in OsteoclastsJournal of Biological Chemistry, 1996
- .alpha.-Hydroxy esters as chiral reagents: asymmetric synthesis of 2-arylpropionic acidsJournal of the American Chemical Society, 1989